Table 1. Cox multivariate regression in high-grade astrocytomas for patients included in the screening cohort (n = 86).
| Variables | n | HR (95% CI) | p-value |
|---|---|---|---|
| Gender (female vs male) | 48/38 | 1.07 (0.68-1.69) | 0.76 |
| Age | 86 | 1.03 (1.01-1.05 | 0.0038* |
| Performance status (KPS ≥80 vs <80) | 71/15 | 0.94 (0.52-1.68) | 0.83 |
| Surgery (resection vs biopsy) | 81/5 | 1.20 (0.43-3.37) | 0.72 |
| Malignancy grade (WHO III vs IV) | 19/67 | 0.66 (0.35-1.23) | 0.19 |
| IDH1 (mutation vs no mutation) | 15/71 | 0.76 (0.38-1.52) | 0.44 |
| PROX1 protein (<50%; 50-90%; >90%) | 8/41/37 | 1.12 (0.76-1.67) | 0.56 |
HR= hazard ratio; CI = confidence interval;
p ≤ 0.05